Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adarza BioSystems

Adarza BioSystems
2008 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series C LATEST DEAL TYPE
$17M LATEST DEAL AMOUNT
18 INVESTORS
Description

Developer of a biological assay platform intended to measure clinical and point-of-care samples. The company's label-free diagnostic platform is capable of simultaneous detection of hundreds of analytes in a single drop of fluid, enabling highly multiplexed protein detection with high sensitivity and specificity.

Formerly Known As
Pathologics Associates
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Primary Office
  • 2184 Welsch Industrial Court
  • Saint Louis, MO 63146
  • United States

+1 (314) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adarza BioSystems’s full profile, request a free trial.

Adarza BioSystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series C) 18-Jul-2018 $17M 000.00 0000 Completed Generating Revenue
9. Later Stage VC (Series B) 15-Apr-2016 000 000.00 0000 Completed Generating Revenue
8. Grant 21-Mar-2016 0000 00.00 Completed Generating Revenue
7. Later Stage VC (Series A) 04-Jun-2014 00.00 00.00 000.00 Completed Generating Revenue
6. Grant 14-May-2013 0000 00000 Completed Startup
5. Grant 01-Jan-2013 00000 00000 Completed Startup
4. Grant 01-Jan-2012 000.00 00000 Completed Startup
3. Grant 01-Jan-2010 00000 00000 Completed Startup
2. Early Stage VC $100K $100K Completed Startup
1. Grant 01-Sep-2009 $1.8M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Adarza BioSystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series A 374,274 $0.001000 $18.2 $18.2 1x $18.2 11.78%
To view this company’s complete Cap Table, request access »

Adarza BioSystems Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MBio Diagnostics Venture Capital-Backed Boulder, CO 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Ithaca, NY 00 000.00 00000000000 000.00
00000000 0000 Formerly VC-backed Warren, NJ 00 00000 000000&0 00000
00000000 000000000 Venture Capital-Backed Berkeley, CA 0 00000 000000000 00000
00000000 Venture Capital-Backed Toronto, Canada 00 0000 0000000000 0
To view this company’s complete list of competitors, request access »

Adarza BioSystems Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3x5 Partners Venture Capital Minority 000 0000 000000 0
CSC UpShot Ventures Venture Capital Minority 000 0000 000000 0
Genoa Ventures Venture Capital Minority 000 0000 000000 0
Hemisphere Ventures Venture Capital Minority 000 0000 000000 0
Jenny Rooke Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Adarza BioSystems Executive Team (8)

Name Title Board
Seat
Contact
Info
Bryan Witherbee President & Chief Executive Officer
Linda Meeh Ph.D Chief Commercial Officer
Christopher Striemer Ph.D Founder & Vice President, Technology

5 Former Executives

You’re viewing 3 of 8 executives. Get the full list »

Adarza BioSystems Board Members (13)

Name Representing Role Since Contact
Info
Andrew Jay Next47 Board Member 000 0000
Benjamine Miller Ph.D Adarza BioSystems Board Member 000 0000
David Smoller Ph.D Self Board Member 000 0000
Heiner Dreismann Ph.D Self Board Member 000 0000
Jay Schmelter RiverVest Venture Partners Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »